What Challenges Do Biotechnology Firms Face in Histology?
Despite their contributions, biotechnology firms face challenges such as high development costs and stringent regulatory requirements. Ensuring the reproducibility and reliability of histological products is crucial, and firms must invest heavily in quality control and validation processes. Furthermore, staying ahead of the curve in an ever-evolving field requires continuous innovation and adaptation.
